IR News
News Page
-
Notice of passing eligibility examination as active pharmaceutical ingredient (API) producing facility by US Food and Drug Administration (FDA)
-
Consolidated Financial Results for 1st Quarter of Fiscal Year 2021(April 1, 2021 through June 30, 2021)
-
Supplemental Documents for 1st Quarter of Fiscal Year 2021
-
Partial amendment of "NOTICE OF THE 106th ORDINARY GENERAL SHAREHOLDERS' MEETING"
-
(Updated) Partial revisions of "Consolidated Financial Results for the Year ended March 31, 2021" and "Supplemental Documents for FY2020"
-
Notice of the 106th Ordinary General Shareholders' Meeting
-
Financial Result for Fiscal Year 2020
-
Supplemental Documents for Fiscal Year 2020
-
Consolidated Financial Results for Fiscal Year 2020 (April 1, 2020 through March 31, 2021)
-
Supplemental Documents for 3rd Quarter of Fiscal Year 2020
-
Summary of 3rd Quarter Report for Fiscal Year 2020 (April 1, 2020 through December 31, 2020)
-
Financial Result for 2nd Quarter of Fiscal Year 2020
-
Supplemental Documents for 2nd Quarter of Fiscal Year 2020
-
Summary of 2nd Quarter of Fiscal Year 2020 (April 1 through September 30, 2020)
-
Supplemental Documents for 1st Quarter of Fiscal Year 2020
-
Summary of 1st Quarter Report for Fiscal Year 2020(April 1, 2020 through June 30, 2020)
-
Financial Result for Fiscal Year 2019(May 22, 2020)
-
Supplemental Documents for Fiscal Year 2019 (1.7MB)
-
Summary of Financial Report for Fiscal Year 2019 (317KB)
-
Supplemental documents for 3rd Quarter Report for Fiscal Year 2019 (2.32MB)
-
Summary of 3rd Quarter Report for Fiscal Year 2019 (April 1, 2019 through December 31, 2019) (185KB)
